Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib

BACKGROUND: Despite reported advances, acquired resistance to tyrosine kinase inhibitors still represents a serious problem in successful cancer treatment. Among this class of drugs, ponatinib (PON) has been shown to have notable long-term efficacy, although its cytotoxicity might be hampered by aut...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Exp Clin Cancer Res
Hoofdauteurs: Corallo, Diana, Pastorino, Fabio, Pantile, Marcella, Mariotto, Elena, Caicci, Federico, Viola, Giampietro, Ponzoni, Mirco, Tonini, Gian Paolo, Aveic, Sanja
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2020
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7507635/
https://ncbi.nlm.nih.gov/pubmed/32962733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01692-x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items